Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wegro_app Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1787088114588209152.png) Wegro App [@wegro_app](/creator/twitter/wegro_app) on x 10.4K followers
Created: 2025-06-29 14:17:29 UTC

Torrent Pharmaceuticals will acquire a controlling stake in J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR, followed by a merger. The deal values JB Pharma at ₹25,689 crores. 🤝 Torrent will acquire a XXXXX% stake through a Share Purchase Agreement (SPA) for ₹11,917 crores, followed by a mandatory open offer. The open offer price is ₹1,639.18 per share. Additionally, Torrent plans to acquire up to XXXX% of equity shares from JB Pharma employees. The merger will result in shareholders of JB Pharma receiving XX shares of Torrent for every XXX shares held.

- 𝗧𝗿𝗮𝗻𝘀𝗮𝗰𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗮𝗶𝗹𝘀:
  ▪ Torrent will acquire a XXXXX% stake via SPA.
  ▪ Open offer to acquire up to XX% of JB Pharma shares.
  ▪ Merger through a scheme of arrangement.

- 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗲:
  ▪ Access to a fast-growing India franchise. 🚀
  ▪ Strengthens market share in the IPM for Torrent.
  ▪ Entry into the CDMO segment.

- 𝗔𝗽𝗽𝗿𝗼𝘃𝗮𝗹𝘀: The transaction is subject to regulatory approvals from SEBI, CCI, NCLT, and Stock Exchanges.

- 𝗔𝗱𝘃𝗶𝘀𝗼𝗿𝘀: Moelis & Company, NovaOne, Khaitan & Co, Ernst and Young, BDO Valuation Advisory LLP, Kotak Investment Banking, Rothschild & Co, Shardul Amarchand Mangaldas & Co, Goldman Sachs (India) Securities Pvt. Ltd. and AZB & Partners acted as advisors.

- 𝗔𝗯𝗼𝘂𝘁 𝗧𝗼𝗿𝗿𝗲𝗻𝘁 𝗣𝗵𝗮𝗿𝗺𝗮:
  ▪ Annual revenues of over Rs XXXXXX crores.
  ▪ Top X in CV, GI, CNS, and Cosmo-Dermatology segments.
  ▪ Presence in 50+ countries.

- 𝗔𝗯𝗼𝘂𝘁 𝗝𝗕 𝗣𝗵𝗮𝗿𝗺𝗮:
  ▪ One of the fastest-growing pharma companies in India.
  ▪ Leading player in the hypertension segment.
  ▪ Exports finished formulations to over XX countries.

- 𝗔𝗯𝗼𝘂𝘁 𝗞𝗞𝗥: A global investment firm.

📊 J B CHEMICALS & PHARMACEUTICALS LTD | 🏷️ Press Release / Media Release

🌐 Details:

⚡️AI-driven WhatsApp updates - Try FREE 👉


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1939327367106982233/c:line.svg)

**Related Topics**
[spa](/topic/spa)
[corporate finance](/topic/corporate-finance)
[$torntpharmns](/topic/$torntpharmns)

[Post Link](https://x.com/wegro_app/status/1939327367106982233)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

wegro_app Avatar Wegro App @wegro_app on x 10.4K followers Created: 2025-06-29 14:17:29 UTC

Torrent Pharmaceuticals will acquire a controlling stake in J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR, followed by a merger. The deal values JB Pharma at ₹25,689 crores. 🤝 Torrent will acquire a XXXXX% stake through a Share Purchase Agreement (SPA) for ₹11,917 crores, followed by a mandatory open offer. The open offer price is ₹1,639.18 per share. Additionally, Torrent plans to acquire up to XXXX% of equity shares from JB Pharma employees. The merger will result in shareholders of JB Pharma receiving XX shares of Torrent for every XXX shares held.

  • 𝗧𝗿𝗮𝗻𝘀𝗮𝗰𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗮𝗶𝗹𝘀: ▪ Torrent will acquire a XXXXX% stake via SPA. ▪ Open offer to acquire up to XX% of JB Pharma shares. ▪ Merger through a scheme of arrangement.

  • 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗲: ▪ Access to a fast-growing India franchise. 🚀 ▪ Strengthens market share in the IPM for Torrent. ▪ Entry into the CDMO segment.

  • 𝗔𝗽𝗽𝗿𝗼𝘃𝗮𝗹𝘀: The transaction is subject to regulatory approvals from SEBI, CCI, NCLT, and Stock Exchanges.

  • 𝗔𝗱𝘃𝗶𝘀𝗼𝗿𝘀: Moelis & Company, NovaOne, Khaitan & Co, Ernst and Young, BDO Valuation Advisory LLP, Kotak Investment Banking, Rothschild & Co, Shardul Amarchand Mangaldas & Co, Goldman Sachs (India) Securities Pvt. Ltd. and AZB & Partners acted as advisors.

  • 𝗔𝗯𝗼𝘂𝘁 𝗧𝗼𝗿𝗿𝗲𝗻𝘁 𝗣𝗵𝗮𝗿𝗺𝗮: ▪ Annual revenues of over Rs XXXXXX crores. ▪ Top X in CV, GI, CNS, and Cosmo-Dermatology segments. ▪ Presence in 50+ countries.

  • 𝗔𝗯𝗼𝘂𝘁 𝗝𝗕 𝗣𝗵𝗮𝗿𝗺𝗮: ▪ One of the fastest-growing pharma companies in India. ▪ Leading player in the hypertension segment. ▪ Exports finished formulations to over XX countries.

  • 𝗔𝗯𝗼𝘂𝘁 𝗞𝗞𝗥: A global investment firm.

📊 J B CHEMICALS & PHARMACEUTICALS LTD | 🏷️ Press Release / Media Release

🌐 Details:

⚡️AI-driven WhatsApp updates - Try FREE 👉

XXX engagements

Engagements Line Chart

Related Topics spa corporate finance $torntpharmns

Post Link

post/tweet::1939327367106982233
/post/tweet::1939327367106982233